J Korean Med Sci.  2023 Apr;38(13):e110. 10.3346/jkms.2023.38.e110.

Comparison of Proportional Mortality Between Korean Atomic Bomb Survivors and the General Population During 1992–2019

• Jeong A
• Moon Sg
• Han Y
• Nam JW
• Kim MK
• Kim I
• Kim YM
• Park B

• KMID: 2541045
• DOI: http://doi.org/10.3346/jkms.2023.38.e110

Abstract

Background
Atomic bombs dropped on Hiroshima and Nagasaki in Japan in August 1945 were estimated to have killed approximately 70,000 Koreans. In Japan, studies on the health status and mortality of atomic bomb survivors compared with the non-exposed population have been conducted. However, there have been no studies related to the mortality of Korean atomic bomb survivors. Therefore, we aimed to study the cause of death of atomic bomb survivors compared to that of the general population.
Methods
Of 2,299 atomic bomb survivors registered with the Korean Red Cross, 2,176 were included in the study. In the general population, the number of deaths by age group was calculated from 1992 to 2019, and 6,377,781 individuals were assessed. Causes of death were categorized according to the Korean Standard Classification of Diseases. To compare the proportional mortality between the two groups, the P value for the ratio test was confirmed, and the Cochran-Armitage trend test and χ 2 test were performed to determine the cause of death according to the distance from the hypocenter.
Results
Diseases of the circulatory system were the most common cause of death (25.4%), followed by neoplasms (25.1%) and diseases of the respiratory system (10.6%) in atomic bomb survivors who died between 1992 and 2019. The proportional mortality associated with respiratory diseases, nervous system diseases, and other diseases among atomic bomb survivors was higher than that of the general population. Of the dead people between 1992 and 2019, the age at death of survivors who were exposed at a close distance was younger than those who were exposed at a greater distance.
Conclusion
Overall, proportional mortality of respiratory diseases and nervous system diseases was high in atomic bomb survivors, compared with the general population. Further studies on the health status of Korean atomic bomb survivors are needed.

Keyword

Atomic Bomb Survivors; Proportional Mortality; Radiation

Reference

1. Korea Atomic Bombs Victim Association. What is an atomic bomb victim? Updated 2022. Accessed September 18, 2022. http://wonpok.or.kr/doc/abomb1.html .

2. Jung Y. A Survey on the Status of Atomic Bomb Survivors and Their Healthy Life. Sejong, Korea: Korea Institute for Health and Social Affairs;2018.

3. Korea Law Information Center. Special Act on the Support for Korean Atomic Bomb Victims (Act 2016. 5. 29; Amended by Act No. 16409, Apr. 30. 2019). Updated 2019. Accessed September 19, 2022. https://www.law.go.kr/lsSc.do?section=&menuId=1&subMenuId=15&tabMenuId=81&eventGubun=060101&query=%EC%9B%90%ED%8F%AD%ED%94%BC%ED%95%B4%EC%9E%90#undefined .

4. Korean Red Cross. Support for atomic bomb survivors. Updated 2022. Accessed September 18, 2022. https://www.redcross.or.kr/business/atomicbomb_support.do .

5. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 2004; 161(6):622–632. PMID: 15161358.

6. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003; 160(4):381–407. PMID: 12968934.

7. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res. 1994; 137(2):Suppl. S17–S67. PMID: 8127952.

8. Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 2012; 177(3):229–243. PMID: 22171960.

9. Lorimore SA, Coates PJ, Wright EG. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene. 2003; 22(45):7058–7069. PMID: 14557811.

10. Kusunoki Y, Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int J Radiat Biol. 2008; 84(1):1–14. PMID: 17852558.

11. Gillies M, Richardson DB, Cardis E, Daniels RD, O’Hagan JA, Haylock R, et al. Mortality from circulatory diseases and other non-cancer outcomes among nuclear workers in France, the United Kingdom and the United States (INWORKS). Radiat Res. 2017; 188(3):276–290. PMID: 28692406.

12. Richardson DB, Cardis E, Daniels RD, Gillies M, Haylock R, Leuraud K, et al. Site-specific solid cancer mortality after exposure to ionizing radiation: a cohort study of workers (INWORKS). Epidemiology. 2018; 29(1):31–40. PMID: 28991003.

13. Song KY, Kim YI, Kim TJ. National Survey on Atomic Bomb Survivors. Sejong, Korea: Korea Institute for Health and Social Affairs;1991.

14. Ju YS, Jhun HJ, Kim JB, Kim JK. Non-cancer diseases of Korean atomic bomb survivors in residence at Hapcheon, Republic of Korea. J Korean Med Sci. 2006; 21(3):385–390. PMID: 16778377.

15. Aveyard P. A fresh look at proportional mortality ratios. Public Health. 1998; 112(2):77–80. PMID: 9581448.

16. Kupper LL, McMichael AJ, Symons MJ, Most BM. On the utility of proportional mortality analysis. J Chronic Dis. 1978; 31(1):15–22. PMID: 641135.

17. Ozasa K, Takahashi I, Grant EJ, Kodama K. Cardiovascular disease among atomic bomb survivors. Int J Radiat Biol. 2017; 93(10):1145–1150. PMID: 28151038.

18. Rahu K. Morbidity and Mortality Among Baltic Chernobyl Cleanup Workers: a Register-Based Cohort Study. Tartu, Estonia: University of Tartu Press;2014.

19. Oh HJ, Yang DM, Kim CH, Jeon JG, Jung NH, Kim CY, et al. Exploring mortality rates for major causes of death in Korea. Open Public Health J. 2019; 12(1):16–25.

20. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168(1):1–64. PMID: 17722996.

21. Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, et al. Solid cancer incidence among the life span study of atomic bomb survivors: 1958–2009. Radiat Res. 2017; 187(5):513–537. PMID: 28319463.

22. Sumner D. Health effects resulting from the Chernobyl accident. Med Confl Surviv. 2007; 23(1):31–45. PMID: 17370857.

23. Lee EJ. Bodies exposed to atomic bomb and pains - focusing on Korean atomic bomb victims. Minjok Yeonku. 2019; (73):165–185.

24. Ozasa K, Grant EJ, Kodama K. Japanese legacy cohorts: the life span study atomic bomb survivor cohort and survivors’ offspring. J Epidemiol. 2018; 28(4):162–169. PMID: 29553058.

25. Fujita S, Kato H, Schull WJ. The LD50 associated with exposure to the atomic bombing of Hiroshima and Nagasaki. J Radiat Res. 1991; 32(Suppl):154–161. PMID: 1762100.

26. Sugiyama H, Misumi M, Sakata R, Brenner AV, Utada M, Ozasa K. Mortality among individuals exposed to atomic bomb radiation in utero: 1950-2012. Eur J Epidemiol. 2021; 36(4):415–428. PMID: 33492551.